OBJECTIVES: Practice guidelines should improve care, but they are not routi
nely followed, in part because of lack of proven benefit. We evaluated the
effect of introducing guidelines for inflammatory bowel disease (MD) on pra
ctice variation and the IBD Quality of Life (IBDQ) score.
METHODS: This was a prospective, controlled, cohort study. A total of 65 pa
tients were matched according to month of visit, diagnosis, and disease act
ivity with control subjects seen 1 yr earlier. Physicians were educated thr
oughout the study regarding the guidelines. Variation was measured by the M
ayo Practice Guideline Score (MPGS), a 15-point assessment of documentation
of diagnosis. nutrition, social support, education, functional status, and
treatment. The IBDQ was measured at baseline and at 1 yr in the interventi
on group and after 1 yr in the control group.
RESULTS: The MPGS was significantly higher in the intervention group compar
ed to the controls (p == 0.002), with median values of 12 versus 11. The IB
DQ median score increased significantly in the intervention group (p < 0.00
1), baseline median of 133 versus 15-month median of 184. However, the fina
l IBDQ was not significantly higher in the intervention group than in the c
ontrols (p = 0.33).
CONCLUSIONS: Practice guidelines for IBD reduce practice variation. The qua
lity of life improved significantly compared to baseline with practice guid
elines, but not compared to controls, perhaps because of the small sample s
ize and homogenous practice setting. The MPGS is a tool that can be used in
day-to-day management of IBD patients. (C) 2001 by Am. Coll. of Gastroente
rology.